The Food and Drug Administration clearance and CE mark position Abbott to sell its Amplatzer Piccolo Delivery System in the U ...
First and only delivery system designed specifically for premature infants with a patent ductus arteriosus (PDA), a life-threatening opening in their heart New delivery system ...
Medical Device Network on MSN
Abbott secures FDA and CE mark approvals for Amplatzer delivery system
Abbott has secured the US Food and Drug Administration (FDA) and CE Mark approvals for its Amplatzer Piccolo delivery system, designed for premature infants diagnosed with patent ductus arteriosus ...
Nicklaus Children's Heart Institute Launches Bedside Transcatheter PDA Closure Offering for Newborns
The minimally invasive procedure involves placing a small catheter through a vein to deliver a tiny device that seals the PDA from within. The newly appointed chief of cardiovascular medicine and ...
ABBOTT PARK, Ill. - Abbott (NYSE:ABT) has received U.S. Food and Drug Administration clearance and CE Mark for its Amplatzer Piccolo Delivery System, the company announced Thursday. The healthcare ...
Nicklaus Children's Heart Institute Launches Bedside Transcatheter PDA Closure Offering for Newborns
New innovative capability brings lifesaving cardiac care directly to the NICU, reducing risks associated with transporting fragile premature infants. MIAMI , Sept. 22, 2025 /PRNewswire/ -- Nicklaus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback